Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-20-042060

EVP, CFO & CBO acquired 3,806 shares (option exercise)

  • EVP, CFO & CBO gave 20,425 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

Mahatme Sandesh · EVP, CFO & CBO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-05-11 Gift : show line 1 in the form −20,425 16,454 D
2020-07-08 Exercise or conversion : show line 2 in the form +2,385 $13.71 $32,698 18,839 D
2020-07-08 Exercise or conversion : show line 3 in the form +218 $13.71 $2,989 19,057 D
2020-07-08 Exercise or conversion : show line 4 in the form +1,203 $32.63 $39,254 20,260 D

Table II: Derivative

3 lines
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2020-07-08 Exercise or conversion : show line 5 in the form Stock option (right to buy) −2,385 $13.71 $32,698 $13.71 2026-02-28 2,385 0 D
2020-07-08 Exercise or conversion : show line 6 in the form Stock option (right to buy) −218 $13.71 $2,989 $13.71 2026-02-28 218 0 D
2020-07-08 Exercise or conversion : show line 7 in the form Stock option (right to buy) −1,203 $32.63 $39,254 $32.63 2027-03-10 1,203 0 D
Loading xslF345X03/doc4.xml…